» Articles » PMID: 23598440

Undernutrition in Patients with COPD and Its Treatment

Overview
Journal Nutrients
Date 2013 Apr 20
PMID 23598440
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disorder of the lung and whole body caused mainly by tobacco smoking. Patients with advanced COPD are in a state of undernutrition, referred to as pulmonary cachexia; the exercise performance and quality of life (QOL) of these patients are deteriorated, the vital prognosis is unfavorable, and the medico-economic burden posed by poorly nourished COPD patients is high. The mainstays of COPD treatment are pharmacotherapy, mainly with bronchodilators, and non-pharmacotherapeutic approaches such as respiratory rehabilitation and nutrition counseling. Nutritional supplement therapy, consisting primarily of high calorie intake, has been demonstrated to be effective for maintaining and improving the muscle strength and exercise tolerance in poorly nourished COPD patients. The efficacy of intake of various nutrients, besides a high calorie intake, for amelioration of the disease state of COPD has also been reported. The roles of adipokines in the pathophysiology of COPD have begun to receive attention recently, and not only their regulatory effects on appetite and nutritional status, but also their influence on systemic inflammation have been increasingly clarified. We review the papers on COPD and nutrition and discuss the role of nutritional supplement therapy in the treatment of COPD.

Citing Articles

The Association Between the CALLY Index and All-Cause Mortality in Patients with COPD: Results from the Cohort Study of NHANES 2007-2010.

Ding Y, Liu Y, Yu J, Cai C, Fu L, Zhu J Int J Chron Obstruct Pulmon Dis. 2025; 20:159-169.

PMID: 39867991 PMC: 11766151. DOI: 10.2147/COPD.S485036.


Total energy expenditure measured using doubly labeled water in adults with major chronic diseases: a systematic review.

Purcell S, Craven S, Limon-Miro A, Elliott S, Melanson E, Tandon P Am J Clin Nutr. 2024; 120(5):1071-1084.

PMID: 39209153 PMC: 11600028. DOI: 10.1016/j.ajcnut.2024.08.023.


The malnutrition in AECOPD and its association with unfavorable outcomes by comparing PNI, GNRI with the GLIM criteria: a retrospective cohort study.

Zhang X, Wang Y, Xu M, Zhang Y, Lyu Q Front Nutr. 2024; 11:1365462.

PMID: 39183991 PMC: 11341410. DOI: 10.3389/fnut.2024.1365462.


Factors Affecting Survival in Severe and Very Severe COPD after Admission in ICUs of Tertiary Care Centers of India (FAST COPD): Study Protocol for a Multicentric Cohort Study.

Arunachala S, Devapal S, Swamy D, Greeshma M, Ul Hussain I, Siddaiah J Indian J Crit Care Med. 2024; 28(6):552-560.

PMID: 39130380 PMC: 11310678. DOI: 10.5005/jp-journals-10071-24728.


Investigation of nutrition status and analysis of 180-day readmission factors in elderly hospitalized patients with COPD.

Liu H, Song J, Wang Z, Wu S, Qiu S, Chen B Aging Clin Exp Res. 2024; 36(1):155.

PMID: 39085739 PMC: 11291564. DOI: 10.1007/s40520-024-02820-9.


References
1.
Vernooy J, Drummen N, van Suylen R, Cloots R, Moller G, Bracke K . Enhanced pulmonary leptin expression in patients with severe COPD and asymptomatic smokers. Thorax. 2008; 64(1):26-32. DOI: 10.1136/thx.2007.085423. View

2.
Keranis E, Makris D, Rodopoulou P, Martinou H, Papamakarios G, Daniil Z . Impact of dietary shift to higher-antioxidant foods in COPD: a randomised trial. Eur Respir J. 2010; 36(4):774-80. DOI: 10.1183/09031936.00113809. View

3.
Weekes C, Emery P, Elia M . Dietary counselling and food fortification in stable COPD: a randomised trial. Thorax. 2008; 64(4):326-31. DOI: 10.1136/thx.2008.097352. View

4.
Koli K, Keski-Oja J . Vitamin D3 regulation of transforming growth factor-beta system in epithelial and fibroblastic cells--relationships to plasminogen activation. J Investig Dermatol Symp Proc. 1996; 1(1):33-8. View

5.
Karakas S, Karadag F, Karul A, Gurgey O, Gurel S, Guney E . Circulating leptin and body composition in chronic obstructive pulmonary disease. Int J Clin Pract. 2005; 59(10):1167-70. DOI: 10.1111/j.1368-5031.2005.00567.x. View